Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: The Hy-C trial
- 1 March 1992
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 19 (4) , 842-850
- https://doi.org/10.1016/0735-1097(92)90529-v
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989
- Effect of Captopril on Progressive Ventricular Dilatation after Anterior Myocardial InfarctionNew England Journal of Medicine, 1988
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986
- Lack of relationship between the short-term hemodynamic effects of captopril and subsequent clinical responses.Circulation, 1984
- Clinical classification of cardiac deaths.Circulation, 1982
- Long-term vasodilator therapy for heart failure: clinical response and its relationship to hemodynamic measurements.Circulation, 1981
- Vasodilator Therapy of Cardiac FailureNew England Journal of Medicine, 1977
- Oral hydralazine therapy for chronic refractory heart failure.Circulation, 1976
- Hemodynamic Effects of Orally Administered Isosorbide Dinitrate in Patients with Congestive Heart FailureCirculation, 1974